Clinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT Cells

Clinical trial NCT03575299 · UNKNOWN

Trial details

NCT number: NCT03575299
Sponsor: Zhinan Yin, Ph.D.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Multi-drug Resistant Tuberculosis

Start date: 2018-06-01
Primary completion: 2021-06-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.